Technology
Health
Pharmaceutical

PLx Pharma

$5.49
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.28 (5.37%) Today
+$0.28 (5.37%) Today

Why Robinhood?

You can buy or sell PLx Pharma and other stocks, options, ETFs, and crypto commission-free!

About

PLx Pharma Inc. Common Stock, also called PLx Pharma, is a late-stage specialty pharmaceutical company, which engages in the development of clinically validated and patent-protected PLxGuard delivery system. Read More Its products include Vazalore 325 mg and PL1200 Ibuprofen 200 mg. The company was founded by Ronald R. Zimmerman on November 12, 2002 and is headquartered in Houston, TX.

Employees
15
Headquarters
Houston, Texas
Founded
2002
Market Cap
45.56M
Price-Earnings Ratio
52.29
Dividend Yield
0.00
Average Volume
20.50K
High Today
$5.49
Low Today
$5.26
Open Price
$5.26
Volume
693.00
52 Week High
$6.44
52 Week Low
$1.00

Collections

Technology
Health
Pharmaceutical
2014 IPO
US
North America
Female CEOs

News

MarketBeatMar 16

Stock Price, News, & Analysis for PLx Pharma

Press coverage about PLXP stock has trended somewhat positive this week, InfoTrie Sentiment reports. The research group identifies positive and negative news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. PLx Pharma earned a daily sentiment score of 2.0 on InfoTrie's scale. They also assigned news articles about the biotech...

0
Seeking AlphaMar 8

PLx Pharma's (PLXP) CEO Natasha Giordano on Q4 2018 Results - Earnings Call Transcript

PLx Pharma's (NASDAQ:PLXP) Q4 2018 Earnings Conference Call March 8, 2019 8:30 AM ET Company Participants Lisa Wilson - IR, In Site Communications Natasha Giordano - President and Chief Executive Officer Rita O'Connor - Chief Financial Officer Conference Call Participants Operator Good day ladies and gentlemen and welcome to PLx Pharma Inc. Fourth Quarter 2018 Results Conference Call. At this time, all participants are in listen-only mode. Later, we will conduct a question-and-answer session, instruc...

27
Seeking AlphaMar 8

PLx Pharma beats by $0.06

PLx Pharma (NASDAQ:PLXP): Q4 Non-GAAP EPS of -$0.31 beats by $0.06; GAAP EPS of $0.34 beats by $0.71. Revenue of $0.29M (-14.7% Y/Y) Press Release...

28

Earnings

-$0.45
-$0.40
-$0.36
-$0.31
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected May 10, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.